You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Alcohol-use disorders

Cirrhosis in over 16s: assessment and management

  • NICE guideline
  • Reference number: NG50
  • Published:  06 July 2016
  • Last updated:  08 September 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence

  • Evidence review

  • Evidence reviews - September 2023

  • A: Clinical and cost-effectiveness of non-selective beta-blockers and endoscopic variceal band ligation for the primary prevention of bleeding in people with oesophageal varices due to cirrhosis (PDF 1.59 MB)

    Published:
    08 September 2023
  • B: Use of antibiotics to prevent spontaneous bacterial peritonitis (PDF 708 KB)

    Published:
    08 September 2023
  • C: Clinical and cost effectiveness of non-selective beta-blockers for the primary prevention of decompensation in people with compensated cirrhosis (PDF 808 KB)

    Published:
    08 September 2023
  • Other supporting evidence

  • Methods (PDF 231 KB)

    Published:
    08 September 2023
  • Surveillance report

  • 2020 surveillance of cirrhosis in over 16s: assessment and management (NICE guideline NG50)

  • Appendix A: Summary of evidence from surveillance (PDF 1.34 MB)

    Published:
    21 October 2020
  • Appendix B: Stakeholder consultation comments table (PDF 911 KB)

    Published:
    21 October 2020
  • Full guidance

  • Appendices A-H (PDF 4.26 MB)

    Published:
    06 July 2016
  • Appendices I-Q (PDF 4.38 MB)

    Published:
    06 July 2016
  • Full guideline - July 2016 (PDF 3.11 MB)

    Published:
    06 July 2016
Back to top